Zhihe Computing is an artificial intelligence and computing company focused on developing high-performance, scalable AI computing CPUs and RISC-V processors. The company specializes in the design of integrated circuit chips aimed at delivering energy-efficient solutions. In addition to chip design, Zhihe Computing offers integrated circuit sales and information system integration services, ensuring its products and services cater to the specific needs of its clients. Through its innovative approach, Zhihe Computing aims to enhance the capabilities of intelligent computing in various applications.
Yuce Biotechnology
Series B in 2024
Yuce Biotechnology is a high-tech company focused on the industrialization of single-molecule immunodiagnostic technologies.
Shengyin Optoelectronics
Series A in 2023
Shengyin Optoelectronics is a micro-nano manufacturing company that specializes in creating ornamental films for electrical appliances and portable electronics. The firm focuses on the research and development of advanced nano-printing and nano-material technologies tailored for the optoelectronics industry. Utilizing techniques such as nano-imprinting, micro-injection molding, micro-electroforming, and nano-printing, Shengyin Optoelectronics produces microstructures with exceptional resolution, reaching up to 30nm on extensive substrate surfaces. Their offerings include surface 2D and 3D structures, ultra-fine conductive lines, and integrated body structures. The company's innovations support various sectors, including consumer electronics, new energy vehicles, solar energy, and biomedical applications.
WITINMEM
Series B in 2023
Beijing Witinmem Technology Co., Ltd., founded in October 2017, specializes in artificial intelligence chips and system solutions utilizing processing-in-memory technology in NOR Flash memory. The company's innovative technology enables the execution of deep neural network inference directly within the NOR Flash memory, which significantly enhances performance, power efficiency, and accuracy. Witinmem's solutions are particularly applicable in speech and image processing, positioning the company at the forefront of low-cost, low-power AI chip development. By facilitating local AI processing independent of cloud resources, Witinmem is dedicated to advancing the integration of AI into everyday smart devices. The company is headquartered in Beijing, China.
Sanyou Bio
Series B in 2022
Sanyou Biopharmaceuticals Co., Ltd. is a contract research organization based in Shanghai, China, specializing in the research and development of innovative antibody drugs. Founded in 2015, the company offers a comprehensive range of services that includes raw material preparation, lead antibody production, optimization of antibody candidates, therapeutic antibody screening, and the establishment of animal models and cell lines. Sanyou has developed over 20 core technological platforms in recent years, focusing on areas such as antibody drug discovery, engineering, and drug efficacy evaluation. With a state-of-the-art R&D laboratory located in Caohejing Hi-Tech Park, Sanyou aims to provide biopharmaceutical companies with effective solutions to enhance patient treatment outcomes.
JKSTACK
Series B in 2022
JKStack is a leading developer of a cloud-based platform that offers comprehensive business automation solutions. The company specializes in creating an end-to-end development environment that integrates integration platform as a service (iPaaS), low-code applications, and augmented data analytics. This platform enables users, both professional and citizen developers, to orchestrate business processes and automate data flow across various systems efficiently and flexibly. By focusing on automated data governance and workflow, JKStack aims to bridge information silos and enhance digital orchestration. The company's innovative approach positions it as a competitive player in the business automation landscape, seeking to redefine IT operations through automation capabilities and deep business integration.
WITINMEM
Series B in 2022
Beijing Witinmem Technology Co., Ltd., founded in October 2017, specializes in artificial intelligence chips and system solutions utilizing processing-in-memory technology in NOR Flash memory. The company's innovative technology enables the execution of deep neural network inference directly within the NOR Flash memory, which significantly enhances performance, power efficiency, and accuracy. Witinmem's solutions are particularly applicable in speech and image processing, positioning the company at the forefront of low-cost, low-power AI chip development. By facilitating local AI processing independent of cloud resources, Witinmem is dedicated to advancing the integration of AI into everyday smart devices. The company is headquartered in Beijing, China.
Sanyou Bio
Series B in 2021
Sanyou Biopharmaceuticals Co., Ltd. is a contract research organization based in Shanghai, China, specializing in the research and development of innovative antibody drugs. Founded in 2015, the company offers a comprehensive range of services that includes raw material preparation, lead antibody production, optimization of antibody candidates, therapeutic antibody screening, and the establishment of animal models and cell lines. Sanyou has developed over 20 core technological platforms in recent years, focusing on areas such as antibody drug discovery, engineering, and drug efficacy evaluation. With a state-of-the-art R&D laboratory located in Caohejing Hi-Tech Park, Sanyou aims to provide biopharmaceutical companies with effective solutions to enhance patient treatment outcomes.
Innovative Cellular Therapeutics
Series C in 2019
Innovative Cellular Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, focused on the research and development of cell therapy. Established in 2009, the company specializes in creating chimeric antigen receptor T (CAR-T) products aimed at treating blood cancers and solid tumors. Its portfolio includes an allogeneic CAR-T development program utilizing gene editing and gene therapy techniques. The company is dedicated to developing cellular immunotherapies for late-stage solid tumors, including colorectal and thyroid cancers, with the goal of improving patient outcomes and enhancing quality of life for those affected by cancer.
Honor Alliance
Series B in 2019
Beijing Honor Alliance Technology Development Co., Ltd, established in 2009, specializes in information technology consulting and technical support services. The company offers a range of solutions including IT operation management, business continuity management consulting, disaster recovery system construction, and risk and emergency management services. Additionally, it provides training for business continuity management authority certification and conducts audit certification. With a presence in multiple cities across China, including Shanghai, Chengdu, Shenzhen, Wuhan, Nanjing, and Zhengzhou, Honor Alliance is positioned to support various enterprises in enhancing their IT capabilities and resilience.
HyperAI Cloud
Angel Round in 2019
HyperAI Cloud Technology (Beijing) Co., Ltd. is a high-tech enterprise established in 2017 that specializes in the development and application of artificial intelligence cloud computing technology. Based in Beijing, the company offers a range of services including industry model algorithm optimization, parallel computing architecture, and cloud computing service delivery. HyperAI Cloud provides a comprehensive solution for AI applications, catering to various fields such as computer vision, speech recognition, and natural language processing. The company aims to facilitate innovation by delivering a robust cloud-based computing and resource management platform that effectively supports developers in managing workflows, resources, and model algorithms. Its entrepreneurial team comprises experienced professionals from leading tech companies, contributing to its commitment to advancing AI technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.